Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

NCT05487651 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

NHL, Relapsed, Adult
B-cell Lymphoma
B-cell Leukemia
DLBCL - Diffuse Large B Cell Lymphoma
ALL, Adult B Cell
ALL, Childhood
CLL/SLL

Interventions

GENETIC: KUR-502

Sponsor

Athenex, Inc.